We’re proud to spotlight Amarastesia SA, part of our 2025 STARTUPsX Alumni, and a meaningful milestone for its Founder & CEO, Dr. Roxana B. Kerns.
Amarastesia SA has been accepted into the Milestone Circles programme at the Nasdaq Entrepreneurial Center , a globally respected initiative supporting founders building with purpose, rigor, and long-term impact, made possible with the support of Wells Fargo .
At the core of Amarastesia’s work lies deeply human innovation. The company develops atraumatic and minimally invasive medical devices designed to enhance patient safety, improve clinical outcomes, and place people, not just technology, at the center of healthcare innovation.
From STARTUPsX to international programmes shaping the future of medicine, this journey is a powerful reminder that thoughtful, patient-centered innovation travels far.
We’re cheering you on, Amarastesia, and we can’t wait to see what’s next. 🌍
